| Online-Ressource |
Verfasst von: | Kallifatidis, Georgios [VerfasserIn]  |
| Beckermann, Benjamin Michael [VerfasserIn]  |
| Groth, Ariane [VerfasserIn]  |
| Schubert, Mario [VerfasserIn]  |
| Apel, Anja [VerfasserIn]  |
| Khamidjanov, Akmal [VerfasserIn]  |
| Ryschich, Eduard [VerfasserIn]  |
| Wenger, Till [VerfasserIn]  |
| Wagner, Wolfgang [VerfasserIn]  |
| Diehlmann, Anke [VerfasserIn]  |
| Saffrich, Rainer [VerfasserIn]  |
| Krause, Ulf [VerfasserIn]  |
| Eckstein, Volker [VerfasserIn]  |
| Mattern, Jürgen [VerfasserIn]  |
| Chai, Minqiang [VerfasserIn]  |
| Schütz, Günther [VerfasserIn]  |
| Ho, Anthony Dick [VerfasserIn]  |
| Gebhard, Martha-Maria [VerfasserIn]  |
| Büchler, Markus W. [VerfasserIn]  |
| Friess, Helmut [VerfasserIn]  |
| Büchler, Peter [VerfasserIn]  |
| Herr, Ingrid [VerfasserIn]  |
Titel: | Improved lentiviral transduction of human mesenchymal stem cells for therapeutic intervention in pancreatic cancer |
Verf.angabe: | G. Kallifatidis, B.M. Beckermann, A. Groth, M. Schubert, A. Apel, A. Khamidjanov, E. Ryschich, T. Wenger, W. Wagner, A. Diehlmann, R. Saffrich, U. Krause, V. Eckstein, J. Mattern, M. Chai, G. Schütz, A.D. Ho, M.M. Gebhard, M.W. Büchler, H. Friess, P. Büchler and I. Herr |
E-Jahr: | 2008 |
Jahr: | 18 January 2008 |
Umfang: | 10 S. |
Illustrationen: | Illustrationen |
Fussnoten: | Gesehen am 14.10.2021 |
Titel Quelle: | Enthalten in: Cancer gene therapy |
Ort Quelle: | New York, NY : Nature Publ. Group, 1999 |
Jahr Quelle: | 2008 |
Band/Heft Quelle: | 15(2008), 4, Seite 231-240 |
ISSN Quelle: | 1476-5500 |
Abstract: | Genetic modification of human bone marrow mesenchymal stem cells (MSC) is highly valuable for their exploitation in basic science and therapeutic applications, for example in cancer. We present here a new, fast and easy-to-use method to enrich a functional population of lentiviral (LV)-transduced MSC expressing enhanced green fluorescent protein (eGFP). We replaced the eGFP gene by a fusion gene of puromycin acetyltransferase and eGFP. Upon LV gene transfer and puromycin selection, we quickly obtained a pure transduced MSC population, in which growth, differentiation capacity and migration preferences were not compromised. Furthermore, we are the first to report the migration velocity of MSC among which 30% were moving and velocity of about 15 μm h−1 was not altered by LV transduction. Manipulated MSC underwent senescence one passage earlier than non-transduced cells, suggesting the use for therapeutic intervention in early passage numbers. Upon tail vein application in nude mice, the majority of LV-transduced MSC could be detected in human orthotopic pancreatic tumor xenografts and to a minor extent in mouse liver, kidney and lung. Together, LV transduction of genes to MSC followed by puromycin selection is a powerful tool for basic research and improves the therapeutic prospects of MSC as vehicles in gene therapy. |
DOI: | doi:10.1038/sj.cgt.7701097 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1038/sj.cgt.7701097 |
| Volltext: https://www.nature.com/articles/7701097 |
| DOI: https://doi.org/10.1038/sj.cgt.7701097 |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1773861697 |
Verknüpfungen: | → Zeitschrift |
Improved lentiviral transduction of human mesenchymal stem cells for therapeutic intervention in pancreatic cancer / Kallifatidis, Georgios [VerfasserIn]; 18 January 2008 (Online-Ressource)